Sarepta Therapeutics, Inc. (SRPT)

Sarepta Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	427.29	428.43	966.78	2,116	1,503	835.08
Short-Term Investments	963.45	1,248	1,023	0	435.92	289.67
Cash & Cash Equivalents	1,391	1,676	1,989	2,116	1,939	1,125
Cash Growth	-26.11%	-15.74%	-5.98%	9.15%	72.36%	-4.19%
Receivables	378.81	400.33	214.63	152.99	101.34	90.88
Inventory	581.07	514.23	366.51	186.21	231.96	171.38
Other Current Assets	114.24	-11.47	-12.65	149.03	213.32	81.91
Total Current Assets	2,465	2,579	2,558	2,604	2,485	1,469
Property, Plant & Equipment	375.57	357.11	244.99	236.69	282.19	167.55
Goodwill and Intangibles	0	0	0	14.24	13.63	12.5
Other Long-Term Assets	383.95	328.14	325.51	292.95	203.7	173.86
Total Long-Term Assets	759.52	685.25	570.51	543.88	499.52	353.91
Total Assets	3,224	3,265	3,128	3,148	2,985	1,823
Accounts Payable	91.54	164.92	95.88	76.74	111.09	68.09
Deferred Revenue	437	487.42	574.24	663.49	752.73	3.3
Current Debt	105.59	105.48	15.49	0	0	0
Other Current Liabilities	-25.41	-104.16	-66	-287.5	-447.8	193.37
Total Current Liabilities	608.71	653.66	619.6	452.73	416.03	264.77
Long-Term Debt	1,274	1,273	1,602	1,138	1,073	729.62
Other Long-Term Liabilities	380.72	478.1	521.94	628.84	734.07	10.25
Total Long-Term Liabilities	1,654	1,752	2,124	1,767	1,807	739.87
Total Liabilities	2,263	2,405	2,743	2,220	2,223	1,005
Total Debt	1,379	1,379	1,617	1,138	1,073	729.62
Debt Growth	7.07%	-14.74%	42.07%	6.11%	47.04%	73.49%
Retained Earnings	-4,410.09	-4,446.21	-3,910.24	-3,206.75	-2,848.13	-2,294
Comprehensive Income	-0.69	0.92	-1.66	-0.02	0	0.05
Shareholders' Equity	961.19	859.34	384.95	928.01	761.76	818.19
Net Cash / Debt	11.4	297.29	372.02	977.48	865.71	395.13
Net Cash / Debt Growth	-98.08%	-20.09%	-61.94%	12.91%	119.10%	-47.55%
Net Cash Per Share	0.11	3.22	4.25	12.03	11.11	5.37
Working Capital	1,856	1,926	1,938	2,151	2,069	1,204
Book Value Per Share	10.23	9.30	4.40	11.42	9.77	11.11

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).